等待開盤 09-20 09:30:00 美东时间
0.000
0.00%
Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.33) by 12.12 percent. This is a 19.57 percent increase over losses of $(0.46) per share from the
08-08 20:40
Rallybio (RLYB) has issued an update. Martin Mackay, Ph.D., has announced his i...
07-24 04:32
TD Cowen analyst Ritu Baral maintained a Buy rating on Rallybio (RLYB – Researc...
06-18 19:25
JP Morgan analyst Anupam Rama downgrades Rallybio (NASDAQ:RLYB) from Overweight to Neutral.
05-16 00:20
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
05-14 00:10
Rallybio (NASDAQ:RLYB) filed a prospectus related to the offer and sale of 3.64M shares of common stock. This prospectus is not an offer to sell. Filing More on Rallybio Rallybio shares gain on invest...
05-11 04:15
HC Wainwright & Co. analyst Mitchell Kapoor reiterates Rallybio (NASDAQ:RLYB) with a Buy and maintains $9 price target.
05-10 19:39
Jonathan Wolleben, an analyst from JMP Securities, reiterated the Buy rating on...
05-10 12:56
摩根大通证券公司:重申Rallybio(RLYB.US)评级,由优于大市调整至优于大市评级, 目标价8.00美元。
04-19 01:21